Introduction
Over the past decade, molecular biological approaches applied to radiobiological questions have uncovered several mechanisms by which cells respond to ionizing radiation. While the overall fate of cells, such as survival or death, remain important study end points, this molecular analysis has also provided insights into the interactions among radiation-induced radicals and diverse classes of molecules in different cellular compartments. DNA remains an important molecular target for radiation-induced damage; however, radiation effects on proteins as components of the cellular response network appear equally important. This is demonstrated by the radiation-induced activation of signal transduction cascades initiated through events in the plasma membrane, the cytoplasm and the nucleus and resulting in cytoprotective and cytotoxic responses. The identification of molecular targets, other than DNA, offers new opportunities for therapeutic attacks on cancer cells, since many of the survival attributes of neoplastic cells are determined by proteins involved in mechanisms of antiapoptosis, cell cycle regulation and damage repair.
Studying the interactions of ionizing radiation with biological response systems poses unique challenges. Direct radiation effects in cells are limited to relatively short-lived primary and secondary ionization events that may be initiated by reactive oxygen and nitrogen species, ROS and RNS, respectively, and may be amplified by intrinsic cellular responses. Despite the random nature of radiation effects, cellular responses to radiation follow a clear temporal sequence leading to the simultaneous activation of multiple molecular targets, including immediate early events of the cellular signal transduction network. Later consequences include changes in gene expression and global cellular responses of death and survival within hours and days. Many of these later responses depend on immediate early events, occurring within minutes of radiation exposure, such as DNA damage signaling and radical-mediated modifications of plasma membrane and cytoplasmic proteins. Despite the nature of radiation-induced cellular responses, relative hierarchies within existing cellular response pathways are preserved, precluding the existence of radiation-specific responses. On the other hand, cells have specific response pathways, generated as a result of cell metabolism, to ROS and RNS. The inherent sensors and amplification mechanisms of these pathways may be utilized by cells in response to oxidative events initiated by ionizing radiation.
This issue of oncogene reviews summarizes, through individual contributions, major directions of molecular radiation biology research. Studies span fundamental radical-protein interactions to molecular aspects of DNA damage, its recognition and repair. Effects on major cellular response cascades determine the interplay with overall cellular responses of survival or death.
Radiation radicals and the fate of cellular macromolecules
Radiation-induced ROS and RNS are likely to interface with physiologically generated reactive oxygen intermediates acting as potent secondary messengers. They have been shown to affect DNA, proteins and subcellular organelles, such as mitochondria. The interactions of ROS/RNS with signal molecules are essential for the activation of signal transduction cascades. As displayed by Drs Mikkelsen and Ward, key molecular modifications include the oxidation of protein Cys residues by hydrogen peroxide, protein Tyr nitration, S-thiolation and -nitrosylation. Such protein modifications, by affecting critical signaling molecules of established cellular signal transduction pathways, represent potential amplification mechanisms. Examples include protein Tyr phosphatases as important regulators of protein phosphorylation. This has led to the hypothesis that radiation-induced ROSs act as shortlived, highly toxic initiators, but that nitric oxide or its derivatives are the actual effectors leading to the activation of signal transduction pathways.
Protein modifications resulting from irradiation critically affect protein stability. Proteasomes control vital cellular processes through their involvement in the degradation of short-lived proteins controlling cell cycle progression, cell signaling and cell death. The rates of protein degradation by proteasomes are modulated by radiation, hydrogen peroxide or cytokines. Drugs acting as specific proteasome inhibitors, like radiation, promote cell cycle arrest and apoptosis in carcinoma cells. Since these processes are extremely sensitive to hydrogen peroxide and N-acetyl-cysteine, proteasomes likely function as redox-sensitive stress sensors. Proteasomemediated protein degradation is faster and represents a mechanism of protein degradation that occurs independently of protein ubiquitinylation. As described by Dr McBride and colleagues, modulation of proteasome activity can have profound effects on transcriptional responses, including cellular TP53 levels.
DNA damage and stress responses
Drs Fei and El-Deiry discuss the importance of TP53 as a checkpoint control protein that is involved in the processing of radiation-induced double-strand breaks (DSBs). TP53 functions primarily through the transcriptional control of target genes that influence multiple response pathways leading to diverse cellular responses after irradiation, including effects that promote cell survival through the induction of growth arrest coupled with DNA damage repair. In contrast, cell death is associated with irreversible growth arrest and apoptosis. These functions contribute to TP53 as an important molecule determining tissue radiosensitivity.
Among other factors, the radiosensitivity of cells is also determined by the expression and function of a family of large proteins with DNA binding properties, and kinases involved in DNA repair. Drs Powell and Kachnic discuss BRCA1 and BRCA2, the proteins associated with breast carcinoma, and their role in the processing of DNA damage. BRCA2 facilitates homologous recombination (HR) repair, requiring interaction with RAD51 as demonstrated by the colocalization of both proteins in nuclear foci during the S phase of the cell cycle. BRCA1 has a more complex role by interacting with BRCA2/RAD51 complexes and affecting transcriptional responses to DNA damage. The rapid development of chromosomal aberrations in BRCA1/-2-deficient cells emphasizes the role of these proteins in maintaining replication fidelity.
Radiation-induced DSBs represent the most severe types of DNA damage, leading to cell death if unrepaired. Drs Valerie and Povirk discuss the two most important forms of DSB repair in mammalian cells, representing the nonhomologous end joining (NHEJ) and HR. HNEJ dominates in mammalian cells as a form of constitutive repair. In contrast, HR is highly regulated by cell cycle phases and inducible signal transduction responses with important consequences for the overall fate of cells.
Changes in transcriptional regulation represent one important adaptation of cells to stress with the obvious aim of improving the cells' repair capacity. As discussed by Dr Criswell and colleagues, the activation or induction of transcription factors (TFs) after irradiation involves complex processes since their expression regulation depends on signal transduction responses and DNA damage recognition. Radiation alters the expression of gene products normally expressed by cells or induces the expression of new genes, typically stressrelated. While the array of genes expressed after irradiation may differ substantially as a function of radiation dose, dose ranges used therapeutically (p3 Gy) have received increased attention. The array of TFs induced or activated by radiation reflects upon the cellular defense mechanisms, including the recognition and repair of DNA and other molecular damage.
Immediate early and many transcriptional responses represent post-translational protein modifications. Intermediate range responses that are reflected in altered gene expression are best studied by gene array analyses. Drs Amundson and Fornace examine altered gene expression after the exposure of cells to radiation and other stresses. The activation of multiple pathways, including ATM/TP53, MAPK and NFkB, ultimately leads to altered gene expression with secondary effects on cell signaling responses and effector genes. These responses are additionally modified or shaped by different cell types, interindividual genetic differences, and cross-communication among signaling pathways, creating a balance of altered cell cycle regulation, DNA repair and apoptosis. Genetic changes, as assessed by gene expression profiling using cDNA microarrays, are also expected to define late effects of radiation.
Radiation-induced DNA damage recognition and initiation of repair is tightly coupled with cellular responses facilitating these functions. As elucidated by Dr Iliakis and colleagues, these are the likely reasons why radiation-induced DNA damage is tightly linked with altered cell cycle regulation and the activation of checkpoint pathways that inhibit progression of cells through the G1 and G2 phases of the cell cycle and also cause transient S-phase delays. Checkpoints, in conjunction with repair, and apoptosis converge to cellular responses of survival or death. Checkpoint activation requires sensors of DNA damage, such as the ATM and ATR proteins and CHK1 and CHK2 kinases, which play critical roles in these responses and are functionally linked to effectors like TP53 and members of the CDC25 family. As a consequence, checkpoint abrogation may be exploited to enhance cancer therapies involving DNA damaging agents.
Dr Huang and colleagues demonstrate that some cellular or tissue responses may not be immediately apparent but are manifested as epigenetic effects long after irradiation. The dogma that radiation exerts its main damaging effects through action on DNA is challenged by the identification of epigenetic phenomena, such as nontargeted bystander effects that lead to genomic instability. The underlying molecular mechanisms contributing to sustained risks after radiation exposure include complex tissue responses. The delayed effects of radiation are likely perpetuated by secreted tissue factors, cell-to-cell communication and/or changes in gene expression. Radiation-induced bystander effects and genomic instability may also synergize towards radiation carcinogenesis.
Cytoprotective and stress responses
Cytoprotective, prosurvival responses have been identified in cells that are exposed to single or repeated, relatively low radiation doses of 1-5 Gy, permitting survival of the majority of cells. As delineated by Dr Schmidt-Ullrich and colleagues, the major signaling components involved in cytoprotective signaling include plasma membrane receptor Tyr kinases (RTKs) and cytoplasmic protein kinases with an ultimate linkage to altered transcription and cell cycle regulation. Irradiation of cells induces the simultaneous activation of multiple ERBB and other RTKs and nonreceptor Tyr kinases, such as members of the SRC family. This simultaneous activation of RTKs has important biological consequences in that the responses of tumor cells depend upon the variable expression of RTKs by any given tumor cells. The ERBB RTK-mediated major radiation-induced cytoprotective response uses preexisting signaling pathways. ERBB1 signals through MAPK, while ERBB2/ERBB3 signal through AKT/ PI3 K. Cumulatively, these responses confer relative radioresistance through pro-proliferative (MAPK) and antiapoptotic responses (PI3 K, AKT). Upon inhibition of a single ERBB receptor, compensatory responses may be furnished, for example, the SRC-dependent activation of ERBB3 under conditions of ERBB1 inhibition. Since ERBB RTK-mediated responses confer radioresistance, their inhibition may be explored for radiosensitization of tumor cells.
The proto-oncogene RAS, mutated in many tumor cells, acts downstream of and in concert with RTKs. As shown by Dr McKenna and colleagues, RAS increases independent of a receptor cellular resistance to ionizing radiation. Since RAS plays an integral role as signal transducer and modifier, it is not surprising that its effects on cellular radiosensitivity covary with a number of other signaling molecules or pathways, such as ERBB1 (and ERBB2) upstream and PI3 K, AKT and PTEN downstream.
RAF is a cytoplasmic Ser/Thr kinase, downstream of RAS and RTKs, that independently affects cellular radiosensitivity. Detailed studies by Drs Kasid and Dritschilo on the molecular mechanisms of cellular radioresistance have identified signal transduction pathways, of which RAF-1 is a critical component. RAF can be linked to the MAPK cascade, RAS, EGFR and NFkB. Since inhibition of c-RAF-1 has radiosensitizing effects in human tumor cells, the use of RAF antisense oligonucleotides has been explored for therapeutic radiosensitization.
In considering the consequences of radiation-induced activation of signal transduction cascades, the MAPK superfamily of signaling components is involved in pleiotropic cytoprotective and cytotoxic responses and has been linked to growth factor-mediated regulation of diverse cellular events, such as proliferation, senescence, differentiation and apoptosis. As shown by Dr Dent and colleagues, ionizing radiation activates multiple MAPK pathways promoting pro-proliferative and cell survival signals. Other MAPK pathways are linked to stress responses, for example, JNK and P38, downstream of death receptors and pro-caspases. Both categories of responses may be autocrine regulated, for example, through transforming growth factor-a and tumor necrosis factor-a. In addition, signals may be modified depending upon the RAS mutational status. Significant interactions exist with other signaling pathways, such as those mediated by PI3K and NF-kB, also involved in cellular radiation responses.
Cytoplasmic protein kinases may also be stimulated by the pleiotropic second messenger ceramide. The sphingolipid ceramide is generated by degradation of sphingomyelin or de novo synthesis by ceramide synthase. Depending upon the cell system, ceramide may induce cell differentiation and proliferation signals through the MAPK1/2 cascades or stress-related responses of apoptosis via the SAPK/JNK pathways. Drs Kolesnick and Fuks discuss the role of ceramide in cellular responses to radiation. Ceramide effects are initiated by its release from the plasma membrane; ceramide induces TP53-independent apoptosis and DNA damage-mediated apoptosis through activation of the mitochondrial ceramide synthase and secondary expression changes of apoptosis regulating proteins. Ceramide may also affect cellular radiosensitivity through one of its metabolites, sphingosine-1-phosphate. These diverse effects of ceramide make it an attractive target for therapeutic radiosensitization.
Tumor phenotypes and radiation therapy responses
As for many other radiation-related phenomena, molecular analyses have changed our understanding of tumor hypoxia. Molecular signatures of tumor cells may affect the tumor microenvironment, as shown by Dr Denko and colleagues. Tumor hypoxia is identified as a prognostic indicator for an aggressive tumor phenotype. The altered physiology of hypoxic tumors is characterized by angiogenesis, local invasion, enhanced rates of distant metastases and altered apoptotic programs. Since this phenotype is determined by altered hypoxia-mediated gene expression, the molecular responses to hypoxic stress can be inferred through identification of hypoxia-regulated genes. While a significant portion of the genome is transcriptionally responsive to hypoxia, studies are complicated by the fact that these coordinated expression changes affect whole families of genes. Once the hypoxic response is unraveled in its molecular details, molecular targets may arise that could be developed to counteract hypoxia as a pathophysiological state conferring radioresistance.
Radiotherapy is a highly effective modality for locoregional treatment of many cancers. Drs Haffty and Glazer have contributed to the improved understanding of cellular responses at the molecular level, and the increasing functional definition of cellular response molecules has advanced clinical research correlating molecular expression signatures with treatment outcomes. Emphasis is placed on the expression of growth factor receptors and gene products involved in the regulation cell cycle, DNA repair, apoptosis and angiogenesis -all involving molecules that affect tumor cell radiosensitivity.
Conclusions
This issue reflects the current state of molecular radiation research that has enhanced our mechanistic understanding of cellular responses to ionizing radiation. Already, a number of potential molecular targets have been identified, the functional modulation of which can be expected to result in tumor radiosensitization. As shown by a number of contributors, this research has already yielded important new opportunities of translating basic research findings to enhancing the toxicity of ionizing radiation for therapeutic exploitation.
